These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12834859)

  • 61. Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon.
    Adams A; Strander H; Cantell K
    J Gen Virol; 1975 Aug; 28(2):207-17. PubMed ID: 170370
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nitric oxide inhibits Epstein-Barr virus DNA replication and activation of latent EBV.
    Kawanishi M
    Intervirology; 1995; 38(3-4):206-13. PubMed ID: 8682618
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The interaction of non-transforming Epstein-Barr virus (EBV) with cell-associated EBV DNA in superinfected lymphoblastoid cell lines.
    Stoerker J; Yajima Y; Glaser R
    Int J Cancer; 1982 Oct; 30(4):385-92. PubMed ID: 6292115
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1.
    Dyson OF; Pagano JS; Whitehurst CB
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724765
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Semisynthesis of (-)-Rutamarin Derivatives and Their Inhibitory Activity on Epstein-Barr Virus Lytic Replication.
    Lin Y; Wang Q; Gu Q; Zhang H; Jiang C; Hu J; Wang Y; Yan Y; Xu J
    J Nat Prod; 2017 Jan; 80(1):53-60. PubMed ID: 28093914
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
    Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
    J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of mitomycin C and hydroxyurea on the expression of the Epstein-Barr virus cycle following P3HR-1 superinfection.
    Moar MH; Klein G
    Intervirology; 1980; 13(3):178-85. PubMed ID: 6246034
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation.
    Huang L; Yang M; Yuan Y; Li X; Kuang E
    Antiviral Res; 2017 Feb; 138():68-78. PubMed ID: 27939840
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Induction of a deoxyuridine triphosphate nucleotidohydrolase activity in Epstein-Barr virus-infected cells.
    Williams MV; Holliday J; Glaser R
    Virology; 1985 Apr; 142(2):326-33. PubMed ID: 2997989
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonuclease, and DNA polymerase in EBV-activated Akata cells.
    Daibata M; Sairenji T
    Virology; 1993 Oct; 196(2):900-4. PubMed ID: 8396819
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.
    Luka J; Kallin B; Klein G
    Virology; 1979 Apr; 94(1):228-31. PubMed ID: 220786
    [No Abstract]   [Full Text] [Related]  

  • 72. Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification.
    Yao GQ; Grill S; Egan W; Cheng YC
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1420-5. PubMed ID: 8395789
    [TBL] [Abstract][Full Text] [Related]  

  • 73. C-1027-induced alterations in Epstein-Barr viral DNA replication in latently infected cultured human Raji cells: relationship to DNA damage.
    McHugh MM; Beerman TA
    Biochemistry; 1999 May; 38(21):6962-70. PubMed ID: 10346918
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epstein-Barr virus carried by Raji cells: a mutant in early functions?
    Kallin B; Klein G
    Intervirology; 1983; 19(1):47-51. PubMed ID: 6298144
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir.
    Hui KF; Cheung AK; Choi CK; Yeung PL; Middeldorp JM; Lung ML; Tsao SW; Chiang AK
    Int J Cancer; 2016 Jan; 138(1):125-36. PubMed ID: 26205347
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rapamycin enhances lytic replication of Epstein-Barr virus in gastric carcinoma cells by increasing the transcriptional activities of immediate-early lytic promoters.
    Wang M; Wu W; Zhang Y; Yao G; Gu B
    Virus Res; 2018 Jan; 244():173-180. PubMed ID: 29169830
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Epstein-Barr virus single-stranded DNA-binding protein: purification, characterization, and action on DNA synthesis by the viral DNA polymerase.
    Tsurumi T; Kobayashi A; Tamai K; Yamada H; Daikoku T; Yamashita Y; Nishiyama Y
    Virology; 1996 Aug; 222(2):352-64. PubMed ID: 8806519
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative efficacy and selectivity of some nucleoside analogs against Epstein-Barr virus.
    Lin JC; Smith MC; Pagano JS
    Antimicrob Agents Chemother; 1985 Jun; 27(6):971-3. PubMed ID: 2992367
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Suitability of Epstein-Barr virus DNA obtained from superinfected Raji cells for complementary RNA hybridization studies.
    Tanaka A
    J Gen Virol; 1977 Feb; 34(2):375-9. PubMed ID: 190349
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A concatenated form of Epstein-Barr viral DNA in lymphoblastoid cell lines induced by transfection with BZLF1.
    Cho MS; Tran VM
    Virology; 1993 Jun; 194(2):838-42. PubMed ID: 8389085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.